How many studies have been conducted on Junctional Adhesion Molecule C?

BiohacksAI has indexed 83 PubMed studies on Junctional Adhesion Molecule C. 14% of studies involve human subjects.

What are the main research areas for Junctional Adhesion Molecule C?

The primary research domains for Junctional Adhesion Molecule C are 🔬 Oncology, 👁️ Vision & Eye, 🔬 Inflammation. This is based on analysis of 83 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Junctional Adhesion Molecule C

A junctional adhesion molecule subtype that is expressed at high levels in PLACENTA; BRAIN; KIDNEY; and PLATELETS. It serves a variety of functions such as mediating leukocyte-platelet interactions, regulating trans-epithelial migration of POLYMORPHONUCLEAR LEUKOCYTES, and acting as a counter receptor for ALPHAM INTEGRIN.

83+ PubMed studies analyzed · Evidence Score: 45.6

Research Domains

Junctional Adhesion Molecule C has been studied across 20 research domains including 🔬 Oncology, 👁️ Vision & Eye, 🔬 Inflammation, 🛡️ Immunity, 🦴 Bone & Joint. The primary research focus is 🔬 Oncology with 19% of studies addressing this area.

Loading evidence profile...

This evidence profile for Junctional Adhesion Molecule C is generated deterministically from 83 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.